2018 PDA Combination Products Workshop
Registration Options
Individual Registration
Group Registration
Program Highlights
At the 2018 PDA Combination Products Workshop gain insight from pharmaceutical and medical device professionals on the development, regulatory approval process, and lifecycle management of drug delivery combination products and use that knowledge to ensure future success for your product and your company!
Listen to the real life experiences of guidance from experienced pharmaceutical and Medical Device professionals detailing the challenges they have, or are currently facing. Learn from their experiences and solutions they have implemented during development, approval and life-cycle management of their Drug Delivery Combination Products. Learn which activities succeeded and lessons learned. Interact with the participants in panel discussions on the issues that are important to the success of your product and company in the future.
Learning Objectives
At the completion of this workshop, attendees will:
- Identify and prospectively address key challenges in the development, approval and manufacture of Drug Delivery Combination Products
- Recognize potential liabilities and opportunities within their organization
- Benchmark their own organization against others in the area
- Explain unique issues and challenges in the development, approval and manufacture of Drug Delivery Combination Products to peers and management
Who Should Attend
Departments
Device Development | Compliance | Operations | Regulatory Affairs | Manufacturing | Pharmaceutical Formulation and Process Development | Business Development | Marketing | Procurement | CMC | Distribution | Packaging | Quality Assurance/Control| Clinical Affairs
Job Function
Manufacture of Parenteral Products | Packaging Scientists & Engineers | Stability Coordinators | Supply Chain | Logistics | Clinical Development | Business Development | Formulators | Device Development and Engineering | Quality Engineers, Quality Professionals, Regulatory and Compliance Professionals
Contact
Workshop Inquiries
Jason E. Brown
Assistant Director, Programs
Tel: +1 (301) 656-5900 ext. 131, Email: [email protected]
Registration Customer Care:
Tel: +1 (301) 656-5900 ext. 115, Email: [email protected]
Exhibition inquiries
David Hall
Vice President, Sales
Tel: +1 (301) 656-5900 ext. 160 Email: [email protected]
Contact
Program Inquiries
Exhibition/Sponsorship Inquiries
Training Course Inquiries
Registration Customer Care
More information coming soon.
GROUP REGISTRATION DISCOUNT: Register 3 people from the same organization as a group (at the same time) for the event and receive the 4th registration free. Other discounts cannot be applied.
GENERAL TERMS AND CONDITIONS: PDA will send you a confirmation letter within one week of payment being received. You must have this confirmation letter to be considered enrolled in a PDA event. If you have submitted a purchase order or requested an invoice, please be advised that a credit card guarantee is needed. PDA reserves the right to modify the material or speakers/trainers without notice or to cancel an event. If an event is cancelled, registrants will be notified by PDA immediately and will receive a credit (registration fee paid). PDA will not be responsible for any costs incurred by registrants due to cancellation. Please note that the attendee list is shared with attendees, trainers, and exhibitors and may be used to follow up on specific areas of interest after the event. Video, photo, and audio recordings are prohibited at all PDA events.
CANCELLATION: If a cancellation request is received 30 days before the event, a credit (registration fee paid minus a 200.00 USD/EUR processing fee) will be given. No credits will be given for cancellation requests received less than 30 days before the event. Cancellation requests must be emailed to [email protected].
Day 1
Wednesday, October 10
7:00 a.m. - 5:15 p.m.
Registration Open
7:15 a.m. - 8:15 a.m.
Continental Breakfast
8:15 a.m. - 8:30 a.m.
Welcome and Opening Remarks from Committee Chair
Lee Leichter, President, P/L Biomedical
|
8:30 am. - 10:00 a.m. |
|
There has been a proliferation of digital tools and devices, and connected combination products, brought forward by Drug and Biologics companies in the last decade, and it seems to be accelerating. These digital things are used in clinical trials, adjuncts to labeling and in advertising and promotional materials, and in prescription and consumer products. In this session, we’ll discuss a few of the many issues (e.g. cybersecurity, impact of differences in drug versus device laws and regulations, company internal cultural adaptations, systems of digital things) that Drug companies face in bringing these new technologies forward. |
|
8:30 a.m. - 9:00 a.m. 9:00 a.m. - 9:30 a.m. 9:30 a.m. - 10:00 a.m. |
9:45 a.m. - 3:45 p.m.
Exhibit Area Open
10:00 a.m. - 10:45 a.m.
Refreshment Break in Exhibit Area
10:45 a.m. - 12:15 p.m.
Concurrent Sessions
|
A1: New Technologies |
| The session will provide an overview of the latest trends for combination products and the future challenges and hurdles the pharma pipelines provide for drug-device developments. In a world which has been strongly driven by new guidelines, regulations and therapies over the last few years, it is important to understand the future requirements and strategies for successful developments. We will discuss new technologies and regulatory options to transfer latest technology trends to clinic and market including insights into innovative delivery systems and their applications. |
|
10:45 a.m. - 11:15 a.m. 11:15 a.m. - 11:45 a.m. 11:45 a.m. - 12:15 p.m. |
|
B1: Products Intended to be Used Together: A Marriage of Convenience or Necessity? |
|
The combination product arena has many players. One area that is often overlooked but has several important challenges is the case where two or more different types of products are intended to be used together but not physically combined as a single entity. These products can be placed into the same packaging or they can reference each other through labeling only. We hear terms like convenience kit, co-packaged combination product, cross-labelled combination product. Are these really different products? Are there any differences in requirements or is this a distinction without a difference? History plays a significant role here that can have an impact on product development and regulatory pathways. Attend this engaging session to hear from regulators and experts in the field with practical experience. |
|
10:45 a.m. - 11:15 a.m. 11:15 a.m. - 11:45 a.m. 11:15 a.m. - 11:45 a.m. |
12:15 p.m. - 1:30 p.m.
Lunch
1:30 p.m. - 3:00 p.m.
Concurrent Sessions
|
A2: Generic and Biosimilar Combination Products |
| More products with delivery systems that were approved years ago are now subject to competition through generic (505(j) ANDA) and biosimilar (351(k) BLA) submissions. These present unique challenges in addition to those facing New Molecular Entity (NME) combination products. Development of these products, including establishing their comparability to the Reference Drugs or Biologics require different development strategies and assessment tools. In addition to validating that the drug entity is the same, Generic and Interchangeable Biosimilar products must establish that the delivery systems do not differ in any significant way, even though the products they are replacing may be old technology, not user friendly and may have never been subjected to the same requirements when they were approved. These presentations and discussions will identify, explain and help with the understanding of these the new approaches and expectations for these products. |
|
1:30 p.m. - 2:00 p.m. 2:00 p.m. - 2:30 p.m. 2:30 p.m. - 3:00 p.m. |
|
B2: Post-Commercialization |
|
Change is an inherent part of the total product life cycle of a combination product. Consideration and management of that change is one of the most critical aspects of a quality management system, yet for combination product manufacturers, it can be nebulous and challenging due to the lack of established processes or best practices. How do manufacturers decide when to handle the change internally, versus notifying the appropriate regulatory body? How do you capture adverse events and where do you report them? How do you maintain a design history file that incorporates changes to the drug and device constituents of combination products? This session will explore best practices to the challenges facing combination product manufacturers including change management, adverse event report and knowledge management throughout the total product life cycle. |
|
1:30 p.m. - 2:00 p.m. 2:00 p.m. - 2:30 p.m. 2:30 p.m. - 3:00 p.m. |
3:00 p.m. - 3:45 p.m.
Refreshment Break in Exhibit Area
|
3:45 p.m. - 5:15 p.m. |
|
Device development requires large financial, technical, and human resource investments. In today’s global economy it is important to be able to reach all available markets to maximize the return on that investment. The expectations from the different global regulatory bodies may vary significantly, even when the intent is the same, namely to provide safe and effective medications for the represented population. This session will discuss a few of these different global regulatory expectations and strategies for overcoming the challenges. |
|
3:45 p.m. - 4:15 p.m. 4:15 p.m. - 4:45 p.m. 4:45 p.m. - 5:15 p.m. |
5:15 p.m.
Closing Remarks from Committee Chair
Lee Leichter, President, P/L Biomedical
Sponsorship and Exhibit Opportunities are Available!
The 2018 PDA Combination Products Workshopwill provide your company the premier opportunity to network with key decision makers in this dynamic field. Find new customers and strengthen current relationships by exhibiting at and/or sponsoring this Workshop.
The Workshop agenda will provide ample opportunity for exhibitors to have face-to-face dialogue and direct information exchange with industry professionals who are involved in development, approval and manufacturing of drug delivery combination products. Attendees will include industry professionals from compliance, CMC, packaging, operations, quality, regulatory affairs, supply chain, procurement, and other technical functions.
Become a sponsor and/or exhibit at the 2018 PDA Drug Delivery Combination Products Workshop to strengthen your brand image, increase your visibility, and gain access to leaders and subject matter experts in the biopharmaceutical industry. For more information, contact:David Hall, Vice President, Sales
Tel: +1 (301) 760-7373
Cell: +1 (240) 688-4405
Fax: +1 (301) 986-0296
Email: [email protected]
Become a Sponsor
Interested in becoming a sponsor? Learn about opportunities and benefits.
Request InformationBecome an Exhibitor
Interested in becoming an exhibitor? Learn about opportunities and benefits.
Request InformationPLEASE READ PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.
Loews Royal Pacific
6300 Hollywood WayOrlando, FL ,
Loews Royal Pacific
6300 Hollywood Way
Orlando, FL USA 32819
Tel: +1 (407)-503-3000
Rate: Single/Double: $205/per night, plus applicable taxes.
Cut Off Date: Thursday, September 6, 2018
(The PDA block of rooms are available on a first come basis and must be secured by the cut-off date to receive the PDA rate). After the cut-off date, rooms will be available at the prevailing rate based on availability.
Hotel Accommodations
A block of rooms have been reserved for meeting participants at the Loews Royal Pacific. The rate is $205 for single or double occupancy. Please note that over 90% of the Royal Pacific guestrooms are double queen rooms. Guestroom rates are subject to State and Local taxes. Reservations must be secured by Thursday, September 6, 2018. After this date, reservations can be made on a space-and rate-available basis only. Check-in time is 4:00 p.m.; check-out time is 11:00 a.m.
To make reservations, individuals may click on the reservation link above or call the Loews Royal Pacific at +1 (888)-430-4999. Please make sure to tell the reservationist that you are with the PDA group attending the 2018 PDA conference to receive the PDA group rate.
Individual Cancellation
Please be aware that obtaining and canceling hotel reservations is the responsibility of the meeting registrant. Individuals will be responsible for payment of their own cancellation fees. The cancellation policy is 72 hours prior to check-in to avoid cancellation fees.
Amenities
Loews Royal Pacific is conveniently located near Universal Orlando™. The venue is a tropical paradise with an unbeatable location right at the epicenter of fun. In addition to enjoying the lagoon-style pool and its own beach. As a guest, PDA attendees get exclusive benefits and access to the theme parks. Each and every one of the 1,000 stylish guest rooms is decorated in an "island chic" style that's as contemporary as it is laidback. The venue also offers a complimentary water taxi to the Universal CityWalk™ area, allowing guest to enjoy a variety of great restaurants and attractions.
Read more about additional information on service and amenities offered at Loews Royal Pacific.
Airport
Orlando International Airport- (MCO) is located 18 miles (about 20-25 minutes) northeast from Loews Royal Pacific.
Ground Transportation
Preferred Vendor
Destination MCO has been selected as the preferred vendor for airport transportation for Loews Hotels at Universal Orlando™. Exclusive chauffeured services begin at $115 (tax and gratuity included) for a sedan and can be charged to your geust room. Reservations are required. Visit or call the concierge at +1 (407)-503-5200.
Shared-Ride and Direct Service Airport Shuttles - Special Discount for PDA Attendees
Mears Transportation offers a shared-ride airport shuttle from Orlando International Airport to Loews Sapphire Falls. Tickets are available at the Mears Transportation counters located inside the baggage claim area on level two, as well as on level one where the shuttle departs for Loews Sapphire Falls Resort every 30 – 40 minutes. Reservations are not required. Pricing is shown below.
- One-way fare: $21 adult or $16 child (ages 3-9)
- Round-trip fare: $33 adult or $25 child (ages 3-9)
Mears Transportation also offers a direct service airport shuttle from Loews Royal Pacific to Orlando International Airport. Travel time is approximately one hour. Reservations are required. Visit or call the concierge at 407.503.5200 at least 24 hours prior to departure.
Taxis
Taxis are on standby at Orlando International Airport, offering service to and from Loews Royal Pacific for an approximate fare of $55 each way, depending on traffic conditions. Standard taxis can accommodate up to four people. Travel time is approximately 30 minutes.
Directions
From Orlando International Airport
Take the north exit onto the Beachline Expressway (State Road 528) West approximately 11 miles to Interstate 4 (I-4) East. Continue on I-4 East to exit 75A (Universal) and turn left onto Universal Boulevard. Continue on Universal Boulevard to Hollywood Way and turn left. Loews Royal Pacific is on the left at 6300 Hollywood Way.
Note: FL-528 is a toll road with two tolls of $0.75 and $1.00 each between Orlando International Airport and Loews Royal Pacific.
From Florida's Turnpike
Take exit 259 (Orlando) onto I-4 West. Travel on I-4 West to exit 74B (Universal) and continue to Hollywood Way. Turn right onto Hollywood Way. Loews Royal Pacific is the second entrance on the right.
From Eastbound Interstate 4
Take exit 75A and continue to Universal Boulevard. Turn left onto Universal Boulevard and travel approximately one-half mile to Hollywood Way. Turn left onto Hollywood Way. Loews Royal Pacific is the first entrance on the left.
From Westbound Interstate 4
Take exit 74B (Universal) and continue to Hollywood Way. Turn right onto Hollywood Way. Loews Royal Pacific is the second entrance on the right.
From Southbound Interstate 95
Take exit 205 (State Road 528). Travel on FL-528 to I-4 East. Travel on I-4 East to exit 75A and continue to Universal Boulevard. Turn left onto Universal Boulevard and travel approximately one-half mile to Hollywood Way. Turn left onto Hollywood Way. Loews Royal Pacific is the first entrance on the left.
From Northbound Interstate 95
Take exit 260B (I-4 West). Travel on I-4 West to exit 74B (Universal) and continue to Hollywood Way. Turn right onto Hollywood Way. Loews Royal Pacific is the first entrance on the left.
Hotel Parking
Self-parking at the Loews Royal Pacific is $22 overnight or $24 daily. Valet parking is $29 overnight or $34 daily.